Article
Cardiac & Cardiovascular Systems
Diogo de Almeida Fernandes, Natalia Antonio, Pedro A. Sousa, Leonor Preto, Marta Madeira, Luis Elvas, Lino Goncalves
Summary: This study aims to assess battery longevity in implantable cardioverter-defibrillators (ICD) and found that the battery longevity of VVI and DDD ICDs matched the industry-projected longevity after 5 years of follow-up, while Medtronic and Biotronik ICDs appeared to have earlier battery depletion.
BMC CARDIOVASCULAR DISORDERS
(2023)
Article
Cardiac & Cardiovascular Systems
Bradley P. Knight, Nicolas Clementy, Anish Amin, Ulrika M. Birgersdotter-Green, Henri Roukoz, Reece Holbrook, Jaimie Manlucu
Summary: The extravascular implantable cardioverter defibrillator (EV ICD) has a longer projected battery life compared to the subcutaneous implantable cardioverter defibrillator (S-ICD), which can significantly reduce long-term complications and healthcare resource consumption.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Benedict M. Wiles, Paul R. Roberts, Venugopal Allavatam, Amit Acharyya, Naresh Vemishetty, Mohamed ElRefai, David G. Wilson, Koushik Maharatna, Hanjie Chen, John M. Morgan
Summary: Mathematical vector rotation can generate a personalized vector that significantly increases the R:T ratio and device eligibility in ineligible S-ICD patients. Vector rotation does not affect ventricular fibrillation detection efficacy, time to VF detection, and tachycardia discrimination.
Article
Cardiac & Cardiovascular Systems
Willeke van der Stuijt, Anne-Floor B. E. Quast, Sarah W. E. Baalman, Koen C. de Wilde, Tom F. Brouwer, Arthur A. M. Wilde, Reinoud E. Knops
Summary: This study demonstrates a low complication rate after S-ICD replacement, with a first shock conversion rate of 91.4% and a median time to battery depletion of 5.9 years.
Review
Cardiac & Cardiovascular Systems
Grzegorz Slawinski, Maciej Kempa, Andrzej Przybylski
Summary: The importance of CIEDs in treating cardiac rhythm disturbances, heart failure, and preventing sudden cardiac death is undeniable. However, CIED therapy is associated with complications, particularly infections, which have a significant impact on prognosis. This review summarizes current knowledge on diagnosing and managing CIED infections and also discusses alternative methods like subcutaneous defibrillators, leadless pacemakers, and wearable cardioverter defibrillators.
REVIEWS IN CARDIOVASCULAR MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Fozia Z. Ahmed, Carina Blomstrom-Lundqvist, Heather Bloom, Christopher Cooper, Christopher Ellis, Andreas Goette, Arnold J. Greenspon, Charles J. Love, Jens Brock Johansen, Francois Philippon, Khaldoun G. Tarakji, Reece Holbrook, Lou Sherfesee, Ying Xia, Swathi Seshadri, Daniel R. Lexcen, Andrew D. Krahn
Summary: The PADIT infection risk score, developed from a large dataset, identified five independent predictors of CIED infection. A validation study using U.S. healthcare claims data confirmed the predictive value of the risk score, especially when combined with prior CIED infection history, in identifying high-risk patients for targeted interventions to reduce CIED infection risk.
Article
Cardiac & Cardiovascular Systems
Maarten Z. H. Kolk, Sanjiv M. Narayan, Paul Clopton, Arthur A. M. Wilde, Reinoud E. Knops, Fleur V. Y. Tjong
Summary: Remote monitoring for ICDs can detect disease progression and device dysfunction early. This study found that in a real-world population, remote monitoring was associated with a reduction in all-cause and cardiac mortality compared to traditional office visits.
Review
Cardiac & Cardiovascular Systems
Johanna B. Tonko, Christopher A. Rinaldi
Summary: Implantable cardioverter-defibrillators (ICDs) have revolutionized the treatment of cardiac diseases. However, there is a need for alternative ICD configurations due to expanding patient groups and increasing complications associated with traditional devices.
Review
Cardiac & Cardiovascular Systems
Vassil Traykov, Carina Blomstrom-Lundqvist
Summary: Infections related to cardiac implantable electronic devices (CIED) are increasing despite preventive strategies. Antibiotic-eluting envelopes (AEEs) have shown promise in preventing CIED infections and are cost-effective.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Thomas F. Deering, John N. Catanzaro, David A. Woodard
Summary: This study found that the use of antibiotics, especially gentamicin, in biologic envelope hydration solution may reduce infection risk in CIED procedures. Additionally, utilizing antibacterial envelopes without adjunct IV ABX may not be sufficient to reduce infection rates.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Mikhael F. El-Chami, Caroline M. Jacobsen, Robert Griffiths, Linda K. Hansen, Nick Wold, Stacey L. Amorosi, Timothy M. Stivland, Bradley P. Knight, Raul Weiss, George E. Mark, Mauro Biffi, Vincent Probst, Pier D. Lambiase, Marc A. Miller, Larry M. Baddour
Summary: The infection rate in de novo transvenous (TV) ICD implants in a Medicare population was 1.9%, with significant predictors of infection including age <70 years, renal disease with dialysis, and complicated diabetes mellitus.
Article
Medicine, General & Internal
Simone Gulletta, Giulio Falasconi, Lorenzo Cianfanelli, Alice Centola, Gabriele Paglino, Manuela Cireddu, Andrea Radinovic, Giuseppe D'Angelo, Alessandra Marzi, Simone Sala, Nicolai Fierro, Caterina Bisceglia, Giovanni Peretto, Nadia Di Muzio, Paolo Della Bella, Pasquale Vergara, Italo Dell'Oca
Summary: This study reports the ten-year real-world experience of a tertiary multidisciplinary teaching hospital in managing patients with cardiac implantable electronic devices (CIEDs) undergoing radiotherapy (RT). The results show infrequent changes in device parameters and occurrence of arrhythmias, with no clinically significant adverse events.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Filippos-Paschalis Rorris, Christos Charitos
Summary: There is conflicting data on the use of implantable cardioverter-defibrillators (ICD) in left ventricular assist device (LVAD) patients. Major guidelines disagree on routine implantation of permanent defibrillators in LVAD recipients, with alternative strategies such as subcutaneous ICDs having disappointing eligibility rates. Wearable cardioverter defibrillators may serve as a bridge to decision for the implantation of a permanent defibrillator in LVAD recipients.
HEART FAILURE REVIEWS
(2021)
Article
Health Care Sciences & Services
Guillaume Thery, Laurent Faroux, Fanny Boyer, Pierre Nazeyrollas, Jean-Pierre Chabert, Damien Metz, Francois Lesaffre
Summary: This study investigated whether patients who receive a first device-delivered electric shock have a poor prognosis even at the time of ICD implantation. The results showed that the exercise test performed at the time of ICD implantation does not predict the occurrence of device-delivered electric shock. These two factors are independent markers of poor prognosis.
JOURNAL OF PERSONALIZED MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Aida Ribera, Emmanuel Gimenez, Gerard Oristrell, Dimelza Osorio, Josep Ramon Marsal, Lidia Garcia-Perez, Monica Ballesteros, Eduard Rodenas, Yassin Belahnech, Roxana Escalona, Nuria Rivas, Ivo Roca-Luque, Ignacio Ferreira-Gonzalez, Mireia Espallargues
Summary: This study evaluated the cost-effectiveness of implantable cardioverter-defibrillators (ICD) for the primary prevention of cardiac arrhythmias. The results showed that ICD systems are cost-effective for patients with ischemic and nonischemic heart disease younger than 68 years old. However, for older nonischemic patients, the cost-effectiveness ratio is higher.
REVISTA ESPANOLA DE CARDIOLOGIA
(2022)
Article
Cardiac & Cardiovascular Systems
Renate B. Schnabel, Elena Andreassi Marinelli, Elena Arbelo, Giuseppe Boriani, Serge Boveda, Claire M. Buckley, A. John Camm, Barbara Casadei, Winnie Chua, Nikolaos Dagres, Mirko de Melis, Lien Desteghe, Soren Zoga Diederichsen, David Duncker, Lars Eckardt, Christoph Eisert, Daniel Engler, Larissa Fabritz, Ben Freedman, Ludovic Gillet, Andreas Goette, Eduard Guasch, Jesper Hastrup Svendsen, Stephane N. Hatem, Karl Georg Haeusler, Jeff S. Healey, Hein Heidbuchel, Gerhard Hindricks, F. D. Richard Hobbs, Thomas Huebner, Dipak Kotecha, Michael Krekler, Christophe Leclercq, Thorsten Lewalter, Honghuang Lin, Dominik Linz, Gregory Y. H. Lip, Maja Lisa Lochen, Wim Lucassen, Katarzyna Malaczynska-Rajpold, Steffen Massberg, Jose L. Merino, Ralf Meyer, Lluis Mont, Michael C. Myers, Lis Neubeck, Teemu Niiranen, Michael Oeff, Jonas Oldgren, Tatjana S. Potpara, George Psaroudakis, Helmut Purerfellner, Ursula Ravens, Michiel Rienstra, Lena Rivard, Daniel Scherr, Ulrich Schotten, Dipen Shah, Moritz F. Sinner, Rudiger Smolnik, Gerhard Steinbeck, Daniel Steven, Emma Svennberg, Dierk Thomas, Mellanie True Hills, Isabelle C. van Gelder, Burcu Vardar, Elena Pala, Reza Wakili, Karl Wegscheider, Mattias Wieloch, Stephan Willems, Henning Witt, Andre Ziegler, Matthias Daniel Zink, Paulus Kirchhof
Summary: This article summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference, which was held in Hamburg in October 2021 and attended by 83 international experts. The consensus paper highlights new evidence-based approaches to improve care for patients with atrial fibrillation (AF), including population-based screening, evolving management strategies, atrial cardiomyopathy characterization, cognitive function assessment, and the role of artificial intelligence (AI).
Letter
Cardiac & Cardiovascular Systems
Jacopo F. Imberti, Marco Vitolo, Giuseppe Boriani
Letter
Cardiac & Cardiovascular Systems
Jacopo F. Imberti, Marco Vitolo, Giuseppe Boriani
Review
Oncology
Giuseppe Boriani, Pierantonio Menna, Riccardo Morgagni, Giorgio Minotti, Marco Vitolo
Summary: Recent data suggests that the risk of ventricular arrhythmias and sudden cardiac death is a class effect of BTK-inhibitors and should be carefully monitored during treatment. Despite the lower occurrence of atrial fibrillation with second-generation BTK inhibitors, caution is warranted before concluding that they are safer than ibrutinib. Long-term follow-up studies show a remarkable benefit of ibrutinib on all-cause mortality, supporting its clinical impact.
Article
Cardiac & Cardiovascular Systems
Wern Yew Ding, Carina Blomstrom-Lundqvist, Laurent Fauchier, Francisco Marin, Tatjana S. Potpara, Giuseppe Boriani, Gregory Y. H. Lip
Summary: This study investigated the absolute risk of ischemic stroke and the predictive performance of the Calculator of Absolute Stroke Risk (CARS) scheme in atrial fibrillation (AF) patients. The results showed that contemporary management of AF was associated with a low risk of ischemic stroke. CARS and CHA(2)DS(2)-VASc score may be helpful in identifying high-risk patients who may benefit from more aggressive treatment and follow-up.
Editorial Material
Cardiac & Cardiovascular Systems
Giuseppe Boriani, Jacopo F. Imberti, Marco Vitolo
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Medicine, General & Internal
Wern Yew Ding, Marco Proietti, Giulio Francesco Romiti, Marco Vitolo, Ameenathul Mazaya Fawzy, Giuseppe Boriani, Francisco Marin, Carina Blomstrom-Lundqvist, Tatjana S. Potpara, Laurent Fauchier, Gregory Y. H. Lip
Summary: This study evaluates the impact of adherence to the Atrial Fibrillation Better Care (ABC) pathway on clinical outcomes in high-risk atrial fibrillation (AF) patients. The results show that adherence to the ABC pathway is associated with a significant reduction in the incidence of composite events in high-risk patients, including all-cause death, thromboembolism, and acute coronary syndrome.
EUROPEAN JOURNAL OF INTERNAL MEDICINE
(2023)
Article
Medicine, General & Internal
Giuseppe Boriani, Federico Guerra, Roberto De Ponti, Antonio D'Onofrio, Michele Accogli, Matteo Bertini, Giovanni Bisignani, Giovanni Battista Forleo, Maurizio Landolina, Carlo Lavalle, Pasquale Notarstefano, Renato Pietro Ricci, Gabriele Zanotto, Pietro Palmisano
Summary: The subsequent waves of the COVID-19 pandemic in Italy had a significant impact on cardiac care. During the first wave, there was a reduction in elective pacemaker, defibrillator, and cardiac resynchronization device implantations, as well as ablations. However, there was a gradual return to pre-pandemic volumes in the later waves, with slower recovery for ablations. Emergency procedures showed recovery during the second wave, with some variations. Remote monitoring was widely implemented during the first wave but needs further implementation.
INTERNAL AND EMERGENCY MEDICINE
(2023)
Article
Medicine, General & Internal
Jacopo F. F. Imberti, Anna Maisano, Francesca Rampini, Melania Minnocci, Filippo Bertuglia, Marta Mantovani, Benedetta Cherubini, Davide A. A. Mei, Leonardo Ferrara, Niccolo Bonini, Anna Chiara Valenti, Marco Vitolo, Giuseppe Longo, Giuseppe Boriani
Summary: The prevalence of acute cardiovascular diseases (CVDs) is increasing in cancer patients, leading to their admission to the emergency department (ED). Approximately 40% of patients present with symptoms potentially related to CVDs, but only a minority are actually diagnosed with acute CVDs.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Health Care Sciences & Services
Marco Vitolo, Valentina Ziveri, Giacomo Gozzi, Chiara Busi, Jacopo Francesco Imberti, Niccolo Bonini, Federico Muto, Davide Antonio Mei, Matteo Menozzi, Marta Mantovani, Benedetta Cherubini, Vincenzo Livio Malavasi, Giuseppe Boriani
Summary: This study examined the association between frailty, the use of digital tools, and patients' digital health literacy. The results showed that frail and pre-frail patients used digital tools and accessed the Internet less frequently compared to robust patients. Additionally, digital health literacy decreased with increasing frailty levels.
JOURNAL OF PERSONALIZED MEDICINE
(2023)
Article
Biology
Igor Diemberger, Alberto Spadotto, Giulia Massaro, Martina Amadori, Liviu Damaschin, Cristian Martignani, Matteo Ziacchi, Mauro Biffi, Nazzareno Galie, Giuseppe Boriani
Summary: Recent guidelines on atrial fibrillation (AF) introduced changes in rate control options, including combining beta-blockers and non-dihydropyridine calcium channel blockers. This study aimed to explore the prognostic impact of patient-specific rate control therapy compared to standard treatment. The analysis of 1112 patients showed no difference in one-year survival between the two groups. The use of non-dihydropyridine calcium channel blockers, alone or in combination with beta-blockers, showed clinical benefit in selected patients with heart failure.
Article
Medicine, General & Internal
Matteo Ziacchi, Giulio Molon, Vittorio Giudici, Giovanni Luca Botto, Miguel Viscusi, Francesco Brasca, Amato Santoro, Antonio Curcio, Michele Manzo, Erminio Mauro, Mauro Biffi, Alessandro Costa, Andrea Dell'Aquila, Maria Carla Casale, Giuseppe Boriani
Summary: This study evaluated the access, acceptance, and adherence of heart failure (HF) patients to an HF-dedicated smartphone application. The results showed that younger patients with higher education are more likely to accept the app and have higher long-term adherence.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Giuseppe Stabile, Federico Guerra, Gianfranco Tola, Pasquale Vergara, Michele Accogli, Matteo Bertini, Giovanni Bisignani, Giovanni Battista Forleo, Carlo Lavalle, Pasquale Notarstefano, Gabriele Zanotto, Maurizio Landolina, Giuseppe Boriani, Renato Pietro Ricci, Antonio D'Onofrio, Roberto De Ponti
Summary: This report summarizes the findings of the 2020 Italian Catheter Ablation Registry, which showed that atrial fibrillation is the most frequently treated arrhythmia with an increasing use of 3D mapping system and near-zero fluoroscopic approach.
GIORNALE ITALIANO DI CARDIOLOGIA
(2023)
Correction
Cardiac & Cardiovascular Systems
Alexander R. Lyon, Teresa Lopez-Fernandez, Liam S. Couch, Riccardo Asteggiano, Marianne C. Aznar, Jutta Bergler-Klein, Giuseppe Boriani, Daniela Cardinale, Raul Cordoba, Bernard Cosyns, David J. Cutter, Evandro de Azambuja, Rudolf A. de Boer, Susan F. Dent, Dimitrios Farmakis, Sofie A. Gevaert, Diana A. Gorog, Joerg Herrmann, Daniel Lenihan, Javid Moslehi, Brenda Moura, Sonja S. Salinger, Richard Stephens, Thomas M. Suter, Sebastian Szmit, Juan Tamargo, Paaladinesh Thavendiranathan, Carlo G. Tocchetti, Peter van der Meer, Helena J. H. van der Pal
EUROPEAN HEART JOURNAL
(2023)
Correction
Cardiac & Cardiovascular Systems
Emma Svennberg, Fleur Tjong, Andreas Goette, Nazem Akoum, Luigi Di Biase, Pierre Bordachar, Giuseppe Boriani, Haran Burri, Giulio Conte, Jean Claude Deharo, Thomas Deneke, Inga Drossart, David Duncker, Janet K. Han, Hein Heidbuchel, Pierre Jais, Marcio Jansen de Oliveira Figueiredo, Dominik Linz, Gregory Y. H. Lip, Katarzyna Malaczynska-Rajpold, Manlio F. Maruez, Corrette Ploem, Kyoko Soejima, Martin K. Stiles, Eric Wierda, Kevin Vernooy, Christophe Leclercq, Christian Meyer, Cristiano Pisani, Hui Nam Pak, Dhiraj Gupta, Helmut Purerfellner, H. J. G. M. C. Crijns, Edgar Antezana Chavez, Stephan Willems, Victor Waldmann, Lukas Dekker, Elaine Wan, Pramesh Kavoor, Mohit K. Turagam, Moritz Sinner